legislate 发表于 2025-3-26 22:02:09
http://reply.papertrans.cn/29/2833/283202/283202_31.pngMILK 发表于 2025-3-27 01:43:11
http://reply.papertrans.cn/29/2833/283202/283202_32.png转折点 发表于 2025-3-27 07:05:49
New developments in drugs enhancing the immune response: activation of lymphocytes and accessory ceects in different ways. On the one hand, they may enhance non-specific effector mechanisms operative in the resistance of infectious agents and to neoplastic cells. On the other hand, they may non-specifically increase specific immune responses elicited by the recognition of antigenic determinants.Strength 发表于 2025-3-27 09:43:02
Drugs as haptens,ergic drug-induced rèactions either during therapy or in circumstances of occupational exposure to the drug. The majority of adverse reactions to drugs are not immunologically mediated but can be understood on the basis of direct toxicity owing to overdosage, to side effects and to secondary effectsBother 发表于 2025-3-27 13:37:31
http://reply.papertrans.cn/29/2833/283202/283202_35.pngCeramic 发表于 2025-3-27 21:50:35
http://reply.papertrans.cn/29/2833/283202/283202_36.pnginsidious 发表于 2025-3-27 23:41:14
Adverse reactions to practolol,e syndrome in a few patients receiving the drug (Assem and Banks, 1973; Raftery and Denman, 1973). During 1974 a hitherto undescribed adverse reaction complex was discerned (Nicholls, 1976). The main features of this rare syndrome are skin rashes (Felix .. 1974), ocular involvement (Wright, 1975) an厌烦 发表于 2025-3-28 02:39:43
Approaches to prevention and treatment of drug allergy,10 to 15 per cent untoward reactions of hospitalised patients to one or the other drug administered to them; among these 40 to 50 per cent are felt to be of allergic nature (Klein .., 1972), which leaves us with an overall incidence of about 5 per cent of allergic reactions to drugs in a population连锁,连串 发表于 2025-3-28 06:26:18
http://reply.papertrans.cn/29/2833/283202/283202_39.pngobscurity 发表于 2025-3-28 12:23:12
Enzymoimmunoassays and related analytical techniques for drugs,wide applicability. Thus it is not surprising that, since the development of the first RIA for a drug, digitoxin (Smith .. 1969), such assays have been introduced for over 60 drugs (Landon and Moffat, 1976), and have proved of great value to the clinical pharmacologist and clinician. Nonetheless, RI